Clinical Trials Directory

Trials / Unknown

UnknownNCT04592055

The Effect of COVID-19 on Diabetes Mellitus

The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Uşak University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Detailed description

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

Conditions

Timeline

Start date
2020-03-20
Primary completion
2020-10-15
Completion
2021-07-01
First posted
2020-10-19
Last updated
2021-05-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04592055. Inclusion in this directory is not an endorsement.